Hamburg pushes science, enforcement in FDA strategy

A regulatory environment driven by developments in science and technology is high on Margaret Hamburg's list of strategic priorities. She considers herself an advocate for the field of regulatory science and a champion of its evolution.

The FDA yesterday released the 50-page Strategic Priorities 2011 - 2015: Responding to the Public Health Challenges of the 21st Century. The document identifies five "cross-cutting areas," including regulatory science. The remaining four target safety in the global supply chain; stronger compliance and enforcement activities; greater attention to such special populations as women, minorities and children; and emergency medical countermeasures.

Regarding compliance and enforcement, the document recaps recent FDA changes, including deadlines for warning letter responses and the means to prioritize post-warning-letter/post-recall follow-up plant inspections. New programs will "sharpen the effectiveness and timeliness of regulatory, compliance and enforcement systems."

- see the FDA release
- here's the document

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.